持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/07/09 | 3,165 | 3,165 | 3,130 | 3,130 | -25 | -0.8% | 45,900 |
| 2026/07/08 | 3,170 | 3,185 | 3,155 | 3,155 | ±0 | ±0% | 70,600 |
| 2026/07/07 | 3,175 | 3,195 | 3,130 | 3,155 | -15 | -0.5% | 163,500 |
| 2026/07/06 | 3,185 | 3,210 | 3,160 | 3,170 | +20 | +0.6% | 59,900 |
| 2026/07/03 | 3,200 | 3,245 | 3,150 | 3,150 | -15 | -0.5% | 51,400 |
| 2026/07/02 | 3,210 | 3,220 | 3,165 | 3,165 | +5 | +0.2% | 47,100 |
| 2026/07/01 | 3,175 | 3,190 | 3,155 | 3,160 | -30 | -0.9% | 49,400 |
| 2026/06/30 | 3,195 | 3,220 | 3,180 | 3,190 | -5 | -0.2% | 66,000 |
| 2026/06/29 | 3,175 | 3,220 | 3,165 | 3,195 | +60 | +1.9% | 63,900 |
| 2026/06/26 | 3,165 | 3,170 | 3,135 | 3,135 | -5 | -0.2% | 54,900 |
| 2026/06/25 | 3,225 | 3,235 | 3,140 | 3,140 | -95 | -2.9% | 65,700 |
| 2026/06/24 | 3,180 | 3,260 | 3,180 | 3,235 | +80 | +2.5% | 52,700 |
| 2026/06/23 | 3,115 | 3,175 | 3,105 | 3,155 | +25 | +0.8% | 46,400 |
| 2026/06/22 | 3,135 | 3,165 | 3,120 | 3,130 | -20 | -0.6% | 42,700 |
| 2026/06/19 | 3,170 | 3,175 | 3,125 | 3,150 | -25 | -0.8% | 86,100 |
| 2026/06/18 | 3,140 | 3,190 | 3,105 | 3,175 | +65 | +2.1% | 66,300 |
| 2026/06/17 | 3,125 | 3,145 | 3,095 | 3,110 | -15 | -0.5% | 74,100 |
| 2026/06/16 | 3,140 | 3,145 | 3,095 | 3,125 | -25 | -0.8% | 48,900 |
| 2026/06/15 | 3,230 | 3,240 | 3,150 | 3,150 | -50 | -1.6% | 43,000 |
| 2026/06/12 | 3,190 | 3,205 | 3,175 | 3,200 | +5 | +0.2% | 48,300 |
| 2026/06/11 | 3,215 | 3,215 | 3,130 | 3,195 | +5 | +0.2% | 42,000 |
| 2026/06/10 | 3,215 | 3,250 | 3,175 | 3,190 | -25 | -0.8% | 40,900 |
| 2026/06/09 | 3,205 | 3,225 | 3,195 | 3,215 | +15 | +0.5% | 40,300 |
| 2026/06/08 | 3,185 | 3,240 | 3,175 | 3,200 | +20 | +0.6% | 56,000 |
| 2026/06/05 | 3,195 | 3,220 | 3,180 | 3,180 | +35 | +1.1% | 39,500 |
| 2026/06/04 | 3,150 | 3,180 | 3,120 | 3,145 | -10 | -0.3% | 61,500 |
| 2026/06/03 | 3,205 | 3,205 | 3,130 | 3,155 | -55 | -1.7% | 53,400 |
| 2026/06/02 | 3,325 | 3,325 | 3,210 | 3,210 | -155 | -4.6% | 57,100 |
| 2026/06/01 | 3,425 | 3,440 | 3,325 | 3,365 | -85 | -2.5% | 75,500 |
| 2026/05/29 | 3,415 | 3,450 | 3,395 | 3,450 | +35 | +1% | 139,300 |
| 2026/05/28 | 3,475 | 3,480 | 3,390 | 3,415 | -60 | -1.7% | 79,000 |
| 2026/05/27 | 3,460 | 3,495 | 3,395 | 3,475 | -20 | -0.6% | 70,900 |
| 2026/05/26 | 3,540 | 3,555 | 3,485 | 3,495 | -45 | -1.3% | 96,100 |
| 2026/05/25 | 3,655 | 3,665 | 3,510 | 3,540 | -115 | -3.1% | 91,300 |
| 2026/05/22 | 3,670 | 3,670 | 3,595 | 3,655 | +10 | +0.3% | 58,200 |
| 2026/05/21 | 3,600 | 3,670 | 3,600 | 3,645 | +95 | +2.7% | 93,000 |
| 2026/05/20 | 3,565 | 3,600 | 3,510 | 3,550 | +15 | +0.4% | 83,800 |
| 2026/05/19 | 3,530 | 3,560 | 3,490 | 3,535 | +50 | +1.4% | 76,400 |
| 2026/05/18 | 3,345 | 3,550 | 3,325 | 3,485 | +70 | +2% | 151,900 |
| 2026/05/15 | 3,330 | 3,450 | 3,315 | 3,415 | +80 | +2.4% | 136,500 |
| 2026/05/14 | 3,340 | 3,365 | 3,310 | 3,335 | -45 | -1.3% | 43,000 |
| 2026/05/13 | 3,395 | 3,410 | 3,360 | 3,380 | -15 | -0.4% | 39,500 |
| 2026/05/12 | 3,400 | 3,455 | 3,380 | 3,395 | -45 | -1.3% | 90,200 |
| 2026/05/11 | 3,400 | 3,465 | 3,400 | 3,440 | +35 | +1% | 73,000 |
| 2026/05/08 | 3,430 | 3,430 | 3,385 | 3,405 | -25 | -0.7% | 80,200 |
| 2026/05/07 | 3,370 | 3,445 | 3,340 | 3,430 | +65 | +1.9% | 92,200 |
| 2026/05/01 | 3,345 | 3,365 | 3,310 | 3,365 | ±0 | ±0% | 56,900 |
| 2026/04/30 | 3,310 | 3,375 | 3,295 | 3,365 | +15 | +0.4% | 86,500 |
| 2026/04/28 | 3,310 | 3,350 | 3,305 | 3,350 | +5 | +0.1% | 58,200 |
| 2026/04/27 | 3,350 | 3,355 | 3,305 | 3,345 | -45 | -1.3% | 65,500 |
51～
100
件表示中 / 4031件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 328,000円 | +7.7% | +11.7% | 2.59% | 11.54倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 科研薬 | 396,500円 | +17.0% | - | 4.79% | 23.10倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ペプチド | 105,650円 | +72.8% | - | 0.00% | 45.29倍 | 2.80倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ネクセラファーマ | 126,700円 | +39.5% | - | 0.00% | 21.05倍 | 1.79倍 |
|
創薬ベンチャー老舗。買収で成長。低分子で定評の英国創薬事業、日本の製造販売が事業２本柱 |
| ゼリア新薬 | 201,300円 | +6.6% | +17.7% | 2.48% | 8.87倍 | 0.82倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
